Moleculin Biotech Inc (MBRX)

Dec 04, 2025

Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight - GlobeNewswire Inc.

Dec 04, 2025

Dec 04, 2025

Geopolitics Watch: Why Moleculin Biotech Inc. stock remains a top recommendationJuly 2025 Reactions & Fast Momentum Entry Tips - BỘ NỘI VỤ

Dec 04, 2025

Dec 04, 2025

How supply shortages influence Moleculin Biotech Inc. (MOL) stockPortfolio Profit Report & Precise Swing Trade Alerts - Newser

Dec 04, 2025

Dec 03, 2025

Why Moleculin Biotech Inc. stock attracts global investors2025 Institutional Moves & Risk Controlled Swing Trade Alerts - Newser

Dec 03, 2025

Dec 03, 2025

Enterprise value to EBITDA ratio of Moleculin Biotech, Inc. – BER:MOL0 - TradingView

Dec 03, 2025

Dec 03, 2025

Price to cash flow ratio of Moleculin Biotech, Inc. – BER:MOL0 - TradingView

Dec 03, 2025

Dec 03, 2025

Why analysts maintain buy rating on Moleculin Biotech Inc. (MOL) stockGDP Growth & Reliable Momentum Entry Alerts - Newser

Dec 03, 2025

Dec 02, 2025

Number of employees of Moleculin Biotech, Inc. – MUN:MOL0 - TradingView

Dec 02, 2025

Dec 02, 2025

Moleculin Biotech, Inc. Financial Statements – FWB:MOL0 - TradingView

Dec 02, 2025

Dec 02, 2025

Non-controlling/minority interest of Moleculin Biotech, Inc. – BER:MOL0 - TradingView

Dec 02, 2025

Dec 02, 2025

Diluted net income available to common stockholders of Moleculin Biotech, Inc. – BER:MOL0 - TradingView

Dec 02, 2025

Dec 02, 2025

Operating income of Moleculin Biotech, Inc. – BER:MOL0 - TradingView

Dec 02, 2025

Dec 02, 2025

Gross profit of Moleculin Biotech, Inc. – BER:MOL0 - TradingView

Dec 02, 2025

Dec 02, 2025

Moleculin Biotech, Inc. Statistics – BER:MOL0 - TradingView

Dec 02, 2025

Dec 02, 2025

Moleculin Biotech, Inc. Cash Flow – BER:MOL0 - TradingView

Dec 02, 2025

Dec 02, 2025

Moleculin Biotech, Inc. Balance Sheet – BER:MOL0 - TradingView

Dec 02, 2025

Dec 02, 2025

Moleculin Biotech: Dividend historical data and projections - MarketScreener

Dec 02, 2025

Dec 02, 2025

Moleculin Biotech, Inc. Reports Financial Results for the First Quarter Ended March 31, 2018 - marketscreener.com

Dec 02, 2025

Dec 02, 2025

How forex fluctuations impact Moleculin Biotech Inc. (MOL) stockWeekly Trend Report & Accurate Intraday Trading Signals - Newser

Dec 02, 2025

Dec 01, 2025

MBRX Stock Reverse Split 2025 Amid Biotech Bankruptcies: Analysts Remain Bullish - Bitget

Dec 01, 2025

Nov 30, 2025

Why Did MBRX Stock Plummet Over 25% Today? - MSN

Nov 30, 2025

Nov 29, 2025

Moleculin Biotech files for stock and warrants offering - MSN

Nov 29, 2025

Nov 28, 2025

Moleculin Biotech To Present Corporate Overview At Virtual Investor Closing Bell Series - Nasdaq

Nov 28, 2025

Nov 28, 2025

Will Moleculin Biotech Inc. stock rally after Fed decisionsJuly 2025 Patterns & Low Drawdown Trading Techniques - moha.gov.vn

Nov 28, 2025

Nov 28, 2025

Moleculin Biotech Bets Big On New Cancer Drug Trials - Finimize

Nov 28, 2025

Nov 27, 2025

Why Moleculin Biotech Inc. stock remains a top recommendationJuly 2025 Review & Free High Return Stock Watch Alerts - BỘ NỘI VỤ

Nov 27, 2025

Nov 27, 2025

Why Moleculin Biotech Inc. stock is considered a top pick2025 Fundamental Recap & Long-Term Investment Growth Plans - BỘ NỘI VỤ

Nov 27, 2025

Nov 26, 2025

Moleculin Biotech stock drops after announcing 1-for-25 reverse split - Investing.com

Nov 26, 2025

Nov 26, 2025

Moleculin Biotech announces 1-for-25 reverse stock split By Investing.com - Investing.com Nigeria

Nov 26, 2025

Nov 26, 2025

Moleculin Biotech Shares Slide After Announcing 1-for-25 Reverse Split - MSN

Nov 26, 2025

Nov 26, 2025

Moleculin Biotech falls after reverse stock split move - TradingView

Nov 26, 2025

Nov 26, 2025

Moleculin to Participate in the Virtual Investor Closing Bell Series - The Manila Times

Nov 26, 2025

Nov 26, 2025

Moleculin Biotech announces 1-for-25 reverse stock split - Investing.com

Nov 26, 2025

Nov 26, 2025

Moleculin Biotech, Inc. Announces 1-for-25 Reverse Stock Split Effective December 1, 2025 - Quiver Quantitative

Nov 26, 2025

Nov 26, 2025

Moleculin Announces Reverse Stock Split - marketscreener.com

Nov 26, 2025

Nov 26, 2025

Moleculin Biotech (Nasdaq: MBRX) Reverse Split to Cut Shares from 51.7M to 2.1M - Stock Titan

Nov 26, 2025

Nov 24, 2025

Moleculin Biotech Reports Increased Loss Amid Ongoing Trials - MSN

Nov 24, 2025

Nov 24, 2025

Moleculin Biotech Releases Corporate Presentation Update - TipRanks

Nov 24, 2025

Nov 24, 2025

Pre Market Movers: OSCR, NITO, CLSD Set The Pace - RTTNews

Nov 24, 2025

Nov 22, 2025

Moleculin Biotech receives Nasdaq delisting notice, plans to appeal By Investing.com - Investing.com Nigeria

Nov 22, 2025

Nov 21, 2025

Moleculin Biotech receives Nasdaq delisting notice, plans to appeal - Investing.com

Nov 21, 2025

Nov 21, 2025

Moleculin Biotech Appeals Nasdaq Delisting Decision - TipRanks

Nov 21, 2025

Nov 21, 2025

[8-K] Moleculin Biotech, Inc. Reports Material Event | MBRX SEC FilingForm 8-K - Stock Titan

Nov 21, 2025

Nov 21, 2025

Moleculin Biotech Releases New Corporate Presentation - MSN

Nov 21, 2025

Nov 21, 2025

Why analysts remain bullish on Moleculin Biotech Inc. stockDividend Hike & Daily Chart Pattern Signal Reports - newser.com

Nov 21, 2025

Nov 21, 2025

Is Moleculin Biotech Inc. (MOL) stock positioned for digital growth eraChart Signals & Stock Timing and Entry Methods - newser.com

Nov 21, 2025

Nov 21, 2025

Market reaction to Moleculin Biotech Inc.’s recent newsWeekly Trade Summary & Safe Entry Momentum Tips - newser.com

Nov 21, 2025

Nov 20, 2025

Published on: 2025-11-20 06:00:51 - newser.com

Nov 20, 2025